New Mesothelioma Treatment Enters Clinical Trial
Patients suffering from mesothelioma may have more options for treatment in the near future
Following promising results in an early test involving animal testing, Baylor College of Medicine Lung Institute is moving forward with a clinical trial of a new mesothelioma treatment.
The new mesothelioma treatment combines immunotherapy with a drug designed to accelerate cell death.
A Deadly Disease
Malignant pleural mesothelioma is a rare and aggressive form of cancer that targets the lungs. In most cases, mesothelioma is fatal. Most patients diagnosed with mesothelioma die within a year and a half of diagnosis.
Approximately 3,000 people are diagnosed with malignant pleural mesothelioma in the United States every year. Many of these cases are the result of exposure to asbestos.
“Progress in advancing long-term survival in pleural mesothelioma has been minimal for decades,” according to Dr. Bryan Burt, associate professor of surgery at Baylor College of Medicine and lead investigator for the study. “The benefit of the current standard treatments for pleural mesothelioma has plateaued.”
Promising Results for New Mesothelioma Treatment
Recent testing on laboratory mice has yielded encouraging results.
The treatment for mesothelioma combines an IV-administered immunotherapy drug called Nivolumab and a modified adenovirus called MTG201, designed specifically to target cancer cells.
According to a statement from the Baylor College of Medicine, the combination therapy has seen “remarkable” results in animal testing.
“This therapy eradicates mouse mesothelioma tumors, rapidly and consistently in an aggressive mouse model of mesothelioma.” -Dr. Bryan Burt
The Mesothelioma Treatment Center hopes to achieve similar results in the clinical trial.
Researchers are seeking 12 patients to participate in the trial. Potential participants must be diagnosed with malignant pleural mesothelioma and have had chemotherapy.
For more information on participating in the trial, please visit the Mesothelioma Treatment Center online or call 1-713-798-6376 for more information.
Do you suffer from mesothelioma due to asbestos exposure?
If you’ve been diagnosed with mesothelioma and believe exposure to asbestos may be responsible, you deserve justice — and you may be entitled to significant financial compensation.
The mesothelioma attorneys at Riddle & Brantley have been fighting for justice for people injured due to the actions of negligent companies since 1985. If a company’s negligence is responsible for your asbestos exposure and resulting mesothelioma, we would love to help you get justice.
Please call 1-800-525-7111 for a no-obligation consultation and case review. You can also complete the short form below if you prefer.
We recently helped the family of an elderly mesothelioma victim recover a total settlement of $850,000 after our investigation revealed that a railroad company was responsible for the victim’s asbestos exposure. Please visit our mesothelioma case results page for more information.
*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.
For a FREE consultation with an experienced mesothelioma lawyer, please call 1-800-525-7111. There is no obligation, and if you decide to hire us to represent you, there is no upfront cost or attorney fee unless we win your case and recover financial compensation for you.
Please call 1-800-525-7111 for a free case review.
“Mesothelioma is a horrible disease and we are committed to seeking justice for those who suffer from it.” -Gene Riddle
Our attorneys have nearly 200 years in combined legal experience and would love to help you if we can.